We are live on ! Find out more
Xponance

Xponance Portfolio holdings

AUM $16.3B Turnover 12.69%
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
Cap. Flow
+$1.58B
Cap. Flow %
11.22%
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
3.5 years
Top 10 Avg Time Held
4.8 years
Top 20 Avg Time Held
3.7 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$110M
2
AAPL icon
Apple
AAPL
+$89M
3
MSFT icon
Microsoft
MSFT
+$81.1M
4
AMZN icon
Amazon
AMZN
+$54.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$45.4M

Sector Composition

Rank Sector Weight
1 Technology 35.95%
2 Financials 11.04%
3 Consumer Discretionary 10.62%
4 Communication Services 10.59%
5 Healthcare 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VICR icon
1001
Vicor
VICR
$10.1B
$520K ﹤0.01%
+3,230
New +$534K
2026 Q1
0 quarters
MSM icon
1002
MSC Industrial Direct
MSM
$7.31B
$520K ﹤0.01%
5,631
+1,248
+28% +$112K
2020 Q2
23 quarters
QLYS icon
1003
Qualys
QLYS
$6.5B
$519K ﹤0.01%
5,907
+704
+14% +$78K
2020 Q2
23 quarters
LAUR icon
1004
Laureate Education
LAUR
$5.4B
$517K ﹤0.01%
14,852
+1,859
+14% +$63.7K
2025 Q1
4 quarters
CROX icon
1005
Crocs
CROX
$5.84B
$517K ﹤0.01%
6,222
+794
+15% +$68K
2021 Q2
19 quarters
ALGM icon
1006
Allegro MicroSystems
ALGM
$5.75B
$515K ﹤0.01%
16,337
+3,601
+28% +$124K
2022 Q4
13 quarters
BTSG icon
1007
BrightSpring Health Services
BTSG
$12.3B
$515K ﹤0.01%
12,077
+3,252
+37% +$131K
2025 Q3
2 quarters
AAOI icon
1008
Applied Optoelectronics
AAOI
$6.47B
$513K ﹤0.01%
+6,065
New +$387K
2026 Q1
0 quarters
COGT icon
1009
Cogent Biosciences
COGT
$4.99B
$511K ﹤0.01%
13,289
+2,345
+21% +$86.6K
2025 Q3
2 quarters
IRT icon
1010
Independence Realty Trust
IRT
$3.51B
$509K ﹤0.01%
34,199
+4,915
+17% +$80.7K
2022 Q1
16 quarters
DOX icon
1011
Amdocs
DOX
$6.34B
$508K ﹤0.01%
7,786
+2,430
+45% +$178K
2022 Q4
13 quarters
NVST icon
1012
Envista
NVST
$3.71B
$503K ﹤0.01%
19,822
+4,619
+30% +$120K
2021 Q2
19 quarters
CDP icon
1013
COPT Defense Properties
CDP
$3.81B
$502K ﹤0.01%
16,400
+2,313
+16% +$72K
2020 Q2
23 quarters
PTCT icon
1014
PTC Therapeutics
PTCT
$5.14B
$502K ﹤0.01%
7,363
+1,191
+19% +$84.3K
2024 Q3
6 quarters
UHAL.B icon
1015
U-Haul Holding Co Series N
UHAL.B
$9.81B
$501K ﹤0.01%
11,219
+2,229
+25% +$106K
2023 Q2
11 quarters
BMI icon
1016
Badger Meter
BMI
$3.73B
$500K ﹤0.01%
3,283
+285
+10% +$44.7K
2023 Q1
12 quarters
THO icon
1017
Thor Industries
THO
$3.52B
$499K ﹤0.01%
6,248
+1,460
+30% +$149K
2020 Q2
23 quarters
CVLT icon
1018
Commault Systems
CVLT
$6.41B
$499K ﹤0.01%
6,406
+875
+16% +$83K
2020 Q2
23 quarters
ROAD icon
1019
Construction Partners
ROAD
$4.57B
$499K ﹤0.01%
4,488
+743
+20% +$89.1K
2024 Q4
5 quarters
NPO icon
1020
Enpro
NPO
$5.95B
$497K ﹤0.01%
1,982
+318
+19% +$79.6K
2024 Q3
6 quarters
PIPR icon
1021
Piper Sandler
PIPR
$4.54B
$495K ﹤0.01%
6,466
+938
+17% +$77K
2024 Q1
8 quarters
OMF icon
1022
OneMain Financial
OMF
$6.3B
$492K ﹤0.01%
9,207
+1,404
+18% +$83.3K
2024 Q3
6 quarters
LIVN icon
1023
LivaNova
LIVN
$4.23B
$492K ﹤0.01%
7,747
+1,098
+17% +$70.8K
2020 Q2
23 quarters
XENE icon
1024
Xenon Pharmaceuticals
XENE
$3.33B
$492K ﹤0.01%
8,465
+2,490
+42% +$115K
2025 Q3
2 quarters
RNG icon
1025
RingCentral
RNG
$6.22B
$492K ﹤0.01%
13,218
+1,159
+10% +$37.3K
2020 Q2
23 quarters

Similar funds

Xponance's Q1 2026 Portfolio in Review

As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.

  • Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
  • Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
  • Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
  • Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
  • Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
  • Xponance opened 165 new positions and closed 49 in Q1 2026.
  • Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.